Wyeth Korea Co., Ltd.

<p><b>Wyeth Korea, Inc.</b> (Baek-Hee Kang, Representative Director and Pres
ident)
  is a multi-national pharmaceutical company established in 1982 through collaboration
  w
ith American Cyanamid and Yuhan Corporation. The company has been active as
  an affiliated company to Wyeth-Aye
rst International, Inc., a division of the
  ethical business of AHP, since the take-over of American Cyanamid b
y AHP (American
  Home Products), a worldwide known research-oriented pharmaceutical company,
  i
n 1994. Its trade name was changed from Yuhan Cyanamid to Wyeth Korea as of
  September 1, 2000 for the new jump
.<br>
  AHP has changed its name to Wyeth to refloect its role as a global research-driven
  
;pharmaceutical company committed to solving the world's health problems through
  leading-edge biotechnology, e
ffective March 11, 2002 </p>
<p>As described in the above, Wyeth Korea, Inc. has contributed to the national <
br>  health and the development of pharmaceutical industry through the introduction
  of innovating tr
eatment drugs to Korea for the past 20 years. The company will
  do its best to promote the national health by s
upplying innovating new drugs
  continuously through the supply line of new drugs from its head office which r>  is equipped with the greatest ability to do research and development in the
  future.